암성 식욕부진-악액질증후군(CACS) 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 예측 기간의 성장은 다제 병용 요법의 중시, 헬스 케어 인프라의 정비 등이 있습니다. 이 기간에 예상되는 주요 동향에는 완화 케어의 발전, 표적 치료의 출현, 약물전달 시스템의 혁신, 의약품 개발에 있어서의 AI의 통합, 맞춤형 의료의 지속적인 진화 등이 있습니다.
암의 유병률 증가는암성 식욕부진-악액질증후군(CACS) 시장의 성장을 가속할 것으로 예측됩니다. 암 환자의 세계 증가는 인구 고령화, 라이프 스타일 변화, 환경 노출, 검출 방법 개선, 의식 증가, 유전 적 소인 및 특정 암과 관련된 느낌 염증 등의 요인에 기인하고 있습니다. 예를 들어, 2024년 8월 영국의 자선 단체인 맥밀런 암 지원(Macmillan Cancer Support)이 발표한 보고서에 따르면 영국에서 300만 명 이상이 암에 걸렸으며 2025년에는 350만 명, 2030년에는 400만 명, 2040년에는 530만 명으로 늘어날 것으로 예상됩니다.
헬스케어 지출 증가도 암성 식욕부진-악액질증후군(CACS) 시장의 성장에 기여할 것으로 예측되고 있습니다. 의료 지출은 의료 서비스에 할당된 총 재원을 의미하며, 공공 및 민간 부문 지출을 모두 포함합니다. 의료비 지출의 증가는 인구 고령화, 만성 질환의 증가, 의료 기술의 발전, 양질의 의료 서비스에 대한 수요 증가와 같은 요인에 의해 주도되고 있습니다. 암성 식욕부진-악액질증후군(CACS)은 환자의 전문적 치료, 영양 지원, 완화 케어를 필요로 함으로써 암 관련 합병증 관리와 관련된 비용을 증가시키고 이 지출 증가에 크게 기여하고 있습니다. 예를 들어, 2024년 5월 영국 정부 부처인 통계청의 데이터에 따르면 2022년부터 2023년까지 명목 기준 총 의료비 지출이 5.6% 증가하여 2022년에 기록한 0.9% 성장률에 비해 상당한 가속도가 붙은 것으로 나타났습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 암성 식욕부진-악액질증후군(CACS) PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 : 성장률 분석
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 암성 식욕부진-악액질증후군(CACS) 전체 시장(TAM)
제6장 시장 세분화
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 : 적응증별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 체중 감소 예방
- 식욕 감소
- 근육 소모
- 염증
- 기타 적응증
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 프로게스트겐
- 코르티코스테로이드
- 병용 요법
- 기타 치료제
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 : 작용기전별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 식욕 자극제
- 항염증제
- 호르몬 요법
- 카나비노이드
- 기타 작용기전
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 경구
- 정맥
- 피하
- 경피
- 기타 투여 경로
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 클리닉
- 홈케어
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 : 체중 감소 예방 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 영양 보충제
- 대사 조절제
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 : 식욕 감소 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 식욕 자극제
- 그렐린 수용체 작용제
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 : 근육 소모 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 단백 동화 작용제
- 선택적 안드로겐 수용체 조절제(SARM)
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 : 염증 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 항염증제
- 사이토카인 억제제
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 : 기타 적응증 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병용 요법
- 지지적 치료 중재
제7장 지역별/국가별 분석
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 암성 식욕부진-악액질증후군(CACS) 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 암성 식욕부진-악액질증후군(CACS) 시장 : 경쟁 구도
- 암성 식욕부진-악액질증후군(CACS) 시장 : 기업 프로파일
- Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Ono Pharmaceutical Co. Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석
- Mundipharma International Limited 개요, 제품 및 서비스, 전략 및 재무 분석
- Yuhan Corporation 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Helsinn Healthcare SA
- AVEO Pharmaceuticals Inc.
- NGM Biopharmaceuticals Inc.
- Larix Bioscience LLC
- Aeterna Zentaris Inc.
- Artelo Biosciences Inc.
- Sapphire Therapeutics Inc.
- Endevica Bio
- AAVogen Inc.
- Actimed Therapeutics Ltd.
- Aphios Corporation
- Betula Pharmaceuticals AB
- Cannabics Pharmaceuticals Inc.
- Creative Medical Technology Holdings Inc.
- Abreos Biosciences Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 암성 식욕부진-악액질증후군(CACS) 시장(2029년) : 새로운 기회를 제공하는 국가
- 암성 식욕부진-악액질증후군(CACS) 시장(2029년) : 새로운 기회를 제공하는 부문
- 암성 식욕부진-악액질증후군(CACS) 시장(2029년) : 성장 전략
제36장 부록
KTH
Cancer anorexia-cachexia syndrome (CACS) is a multifaceted and complex condition commonly seen in cancer patients, marked by significant metabolic disturbances. It arises from a combination of inflammatory responses, hormonal fluctuations, and impaired nutrient utilization, often leading to poor prognosis and resistance to treatment.
The key aspects of CACS management include preventing weight loss, addressing appetite suppression, reducing muscle wasting, and controlling inflammation. Strategies for weight loss prevention aim to sustain body weight and muscle mass by enhancing nutritional intake and counteracting cancer-related metabolic disruptions. Various therapeutic approaches, including corticosteroids and combination treatments, are employed to manage CACS. These treatments function through different mechanisms, such as appetite stimulation, anti-inflammatory effects, hormonal modulation, and cannabinoid-based interventions. They are administered via multiple routes, including oral, intravenous, subcutaneous, and transdermal delivery, and are utilized in various healthcare settings, such as hospitals, clinics, and home care environments.
The cancer anorexia-cachexia syndrome (CACS) market research report is one of a series of new reports from The Business Research Company that provides cancer anorexia-cachexia syndrome (CACS) market statistics, including the cancer anorexia-cachexia syndrome (CACS) industry global market size, regional shares, competitors with the cancer anorexia-cachexia syndrome (CACS) market share, detailed cancer anorexia-cachexia syndrome (CACS) market segments, market trends, and opportunities, and any further data you may need to thrive in the cancer anorexia-cachexia syndrome (CACS) industry. This cancer anorexia-cachexia syndrome (CACS) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cancer anorexia-cachexia (CACS) syndrome market size has grown rapidly in recent years. It will grow from $3.51 billion in 2024 to $3.89 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth during the historic period was driven by the increasing prevalence of cancer, heightened awareness among healthcare professionals, a stronger emphasis on enhancing the quality of life for cancer patients, the expansion of clinical trials, and the rise in pharmaceutical collaborations and partnerships.
The cancer anorexia-cachexia (CACS) market size is expected to see rapid growth in the next few years. It will grow to $5.84 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The projected growth during the forecast period can be attributed to higher cancer survival rates, increased investments in oncology supportive care, the expansion of personalized medicine, a greater emphasis on multimodal therapies, and the development of healthcare infrastructure. Key trends expected in this period include advancements in palliative care, the emergence of targeted therapies, innovations in drug delivery systems, the integration of AI in drug development, and the continued evolution of personalized medicine.
The increasing prevalence of cancer is expected to drive the growth of the cancer anorexia-cachexia syndrome market. Cancer encompasses a wide range of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The global rise in cancer cases is attributed to factors such as an aging population, lifestyle changes, environmental exposures, improved detection methods, heightened awareness, genetic predispositions, and infections associated with certain cancers. Cancer anorexia-cachexia syndrome (CACS) plays a crucial role in addressing this growing prevalence by managing severe weight loss and malnutrition in cancer patients, ultimately enhancing their quality of life and treatment outcomes. For example, in August 2024, a report published by Macmillan Cancer Support, a UK-based charitable organization, indicated that over 3 million people in the UK are living with cancer, with projections estimating an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the rising prevalence of cancer is fueling the expansion of the cancer anorexia-cachexia syndrome market.
The rise in healthcare expenditure is also anticipated to contribute to the growth of the cancer anorexia-cachexia syndrome market. Healthcare expenditure refers to the total financial resources allocated to healthcare services, encompassing both public and private sector spending. The increase in healthcare expenditure is driven by factors such as an aging population, the growing incidence of chronic diseases, advancements in medical technology, and a heightened demand for quality healthcare services. Cancer anorexia-cachexia syndrome (CACS) significantly contributes to this rising expenditure by requiring specialized treatments, nutritional support, and palliative care for patients, thereby increasing the costs associated with managing cancer-related complications. For instance, in May 2024, data from the Office for National Statistics, a UK-based government department, revealed a 5.6% rise in total healthcare expenditure in nominal terms from 2022 to 2023, representing a substantial acceleration compared to the 0.9% growth recorded in 2022. This increasing healthcare expenditure is a key factor driving the expansion of the cancer anorexia-cachexia syndrome market.
Leading companies in the cancer anorexia-cachexia syndrome market are prioritizing the development of innovative solutions, such as monoclonal antibody therapies, to enhance treatment efficacy, improve patient outcomes, and address unmet clinical needs. Monoclonal antibody therapies involve laboratory-engineered antibodies designed to target specific antigens on cancer cells, aiding the immune system in recognizing and attacking them more effectively. For example, in September 2024, Pfizer Inc., a US-based pharmaceutical and biotechnology corporation, reported positive results from a Phase II clinical trial of ponsegromab, a monoclonal antibody targeting Growth/Differentiation Factor 15 (GDF-15). The promising findings from this study offer new hope for patients suffering from this debilitating condition, which currently has limited effective treatments. The Phase II trial results indicate significant progress in addressing the inflammatory processes that contribute to muscle loss and weight decline in cancer patients. This novel treatment approach aims not only to improve physical function but also to enhance the overall quality of life for cancer patients, representing a crucial advancement in oncology care.
Major players in the cancer anorexia-cachexia syndrome (cacs) market are Pfizer Inc., Merck & Co. Inc., Ono Pharmaceutical Co. Ltd., Mundipharma International Limited, Yuhan Corporation, Helsinn Healthcare SA, AVEO Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Larix Bioscience LLC, Aeterna Zentaris Inc., Artelo Biosciences Inc., Sapphire Therapeutics Inc., Endevica Bio, AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Betula Pharmaceuticals AB, Cannabics Pharmaceuticals Inc., Creative Medical Technology Holdings Inc., Abreos Biosciences Inc.
North America was the largest region in the cancer anorexia-cachexia (CACS) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cancer anorexia-cachexia (CACS) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cancer anorexia-cachexia syndrome (CACS) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cancer anorexia-cachexia syndrome (CACS) market consists of revenues earned by entities by providing services such as nutritional support, pharmacological treatments, palliative care, clinical trials, and research services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cancer Anorexia-Cachexia Syndrome (CACS) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cancer anorexia-cachexia syndrome (cacs) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cancer anorexia-cachexia syndrome (cacs) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer anorexia-cachexia syndrome (cacs) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Indication: Weight Loss Prevention; Appetite Loss; Muscle Wasting; Inflammation; Other Indications
- 2) By Therapeutics: Progestogen; Corticosteroid; Combination Therapy; Other Therapeutics
- 3) By Mechanism Of Action: Appetite Stimulants; Anti-inflammatory Agents; Hormone Therapies; Cannabinoids; Other Mechanism Of Actions
- 4) By Route of Administration: Oral; Intravenous; Subcutaneous; Transdermal; Other Route of Administration
- 5) By Application: Hospitals; Clinics; Home Care
- Subsegments:
- 1) By Weight Loss Prevention: Nutritional Supplements; Metabolic Modulators
- 2) By Appetite Loss: Appetite Stimulants; Ghrelin Receptor Agonists
- 3) By Muscle Wasting: Anabolic Agents; Selective Androgen Receptor Modulators (SARMs)
- 4) By Inflammation: Anti-Inflammatory Drugs; Cytokine Inhibitors
- 5) By Other Indications: Combination Therapies; Supportive Care Interventions
- Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Ono Pharmaceutical Co. Ltd.; Mundipharma International Limited; Yuhan Corporation
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cancer Anorexia-Cachexia Syndrome (CACS) Market Characteristics
3. Cancer Anorexia-Cachexia Syndrome (CACS) Market Trends And Strategies
4. Cancer Anorexia-Cachexia Syndrome (CACS) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Cancer Anorexia-Cachexia Syndrome (CACS) Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cancer Anorexia-Cachexia Syndrome (CACS) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market Growth Rate Analysis
- 5.4. Global Cancer Anorexia-Cachexia Syndrome (CACS) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cancer Anorexia-Cachexia Syndrome (CACS) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cancer Anorexia-Cachexia Syndrome (CACS) Total Addressable Market (TAM)
6. Cancer Anorexia-Cachexia Syndrome (CACS) Market Segmentation
- 6.1. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Weight Loss Prevention
- Appetite Loss
- Muscle Wasting
- Inflammation
- Other Indications
- 6.2. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Progestogen
- Corticosteroid
- Combination Therapy
- Other Therapeutics
- 6.3. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Appetite Stimulants
- Anti-inflammatory Agents
- Hormone Therapies
- Cannabinoids
- Other Mechanism Of Actions
- 6.4. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Intravenous
- Subcutaneous
- Transdermal
- Other Route of Administration
- 6.5. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Home Care
- 6.6. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market, Sub-Segmentation Of Weight Loss Prevention, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nutritional Supplements
- Metabolic Modulators
- 6.7. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market, Sub-Segmentation Of Appetite Loss, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Appetite Stimulants
- Ghrelin Receptor Agonists
- 6.8. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market, Sub-Segmentation Of Muscle Wasting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anabolic Agents
- Selective Androgen Receptor Modulators (SARMs)
- 6.9. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market, Sub-Segmentation Of Inflammation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anti-Inflammatory Drugs
- Cytokine Inhibitors
- 6.10. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market, Sub-Segmentation Of Other Indications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Combination Therapies
- Supportive Care Interventions
7. Cancer Anorexia-Cachexia Syndrome (CACS) Market Regional And Country Analysis
- 7.1. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 8.1. Asia-Pacific Cancer Anorexia-Cachexia Syndrome (CACS) Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 9.1. China Cancer Anorexia-Cachexia Syndrome (CACS) Market Overview
- 9.2. China Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 10.1. India Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 11.1. Japan Cancer Anorexia-Cachexia Syndrome (CACS) Market Overview
- 11.2. Japan Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 12.1. Australia Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 13.1. Indonesia Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 14.1. South Korea Cancer Anorexia-Cachexia Syndrome (CACS) Market Overview
- 14.2. South Korea Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 15.1. Western Europe Cancer Anorexia-Cachexia Syndrome (CACS) Market Overview
- 15.2. Western Europe Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 16.1. UK Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 17.1. Germany Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 18.1. France Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 19.1. Italy Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 20.1. Spain Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 21.1. Eastern Europe Cancer Anorexia-Cachexia Syndrome (CACS) Market Overview
- 21.2. Eastern Europe Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 22.1. Russia Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 23.1. North America Cancer Anorexia-Cachexia Syndrome (CACS) Market Overview
- 23.2. North America Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 24.1. USA Cancer Anorexia-Cachexia Syndrome (CACS) Market Overview
- 24.2. USA Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 25.1. Canada Cancer Anorexia-Cachexia Syndrome (CACS) Market Overview
- 25.2. Canada Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 26.1. South America Cancer Anorexia-Cachexia Syndrome (CACS) Market Overview
- 26.2. South America Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 27.1. Brazil Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 28.1. Middle East Cancer Anorexia-Cachexia Syndrome (CACS) Market Overview
- 28.2. Middle East Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cancer Anorexia-Cachexia Syndrome (CACS) Market
- 29.1. Africa Cancer Anorexia-Cachexia Syndrome (CACS) Market Overview
- 29.2. Africa Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Cancer Anorexia-Cachexia Syndrome (CACS) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cancer Anorexia-Cachexia Syndrome (CACS) Market Competitive Landscape And Company Profiles
- 30.1. Cancer Anorexia-Cachexia Syndrome (CACS) Market Competitive Landscape
- 30.2. Cancer Anorexia-Cachexia Syndrome (CACS) Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Ono Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Mundipharma International Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Yuhan Corporation Overview, Products and Services, Strategy and Financial Analysis
31. Cancer Anorexia-Cachexia Syndrome (CACS) Market Other Major And Innovative Companies
- 31.1. Helsinn Healthcare SA
- 31.2. AVEO Pharmaceuticals Inc.
- 31.3. NGM Biopharmaceuticals Inc.
- 31.4. Larix Bioscience LLC
- 31.5. Aeterna Zentaris Inc.
- 31.6. Artelo Biosciences Inc.
- 31.7. Sapphire Therapeutics Inc.
- 31.8. Endevica Bio
- 31.9. AAVogen Inc.
- 31.10. Actimed Therapeutics Ltd.
- 31.11. Aphios Corporation
- 31.12. Betula Pharmaceuticals AB
- 31.13. Cannabics Pharmaceuticals Inc.
- 31.14. Creative Medical Technology Holdings Inc.
- 31.15. Abreos Biosciences Inc.
32. Global Cancer Anorexia-Cachexia Syndrome (CACS) Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cancer Anorexia-Cachexia Syndrome (CACS) Market
34. Recent Developments In The Cancer Anorexia-Cachexia Syndrome (CACS) Market
35. Cancer Anorexia-Cachexia Syndrome (CACS) Market High Potential Countries, Segments and Strategies
- 35.1 Cancer Anorexia-Cachexia Syndrome (CACS) Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cancer Anorexia-Cachexia Syndrome (CACS) Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cancer Anorexia-Cachexia Syndrome (CACS) Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
